Contract manufacturing giant Catalent has announced that it will set up a new biologics analytical center of excellence in North Carolina’s Research Triangle. The new plant will offer analytical development and testing services for biologics, including cell and gene therapies. Catalent obtained a Job Development Investment Grant (JDIG) from the North Carolina Economic Investment Committee…
Lilly and EVA Pharma partner to improve insulin access in Africa
Eli Lilly and Company (NYSE: LLY) and Egypt-headquartered EVA Pharma have developed a plan to collaborate to supply at least one million people in low- and middle-income countries. Many of the recipients of the vaccines will be in Africa. Roughly a month ago, Lilly’s share price fell about 4% after a fake Twitter account stated…
As Adderall shortage persists, many doctors are concerned
Supplies of the ADHD drug Adderall (amphetamine and dextroamphetamine) remain limited, forcing millions of patients to either search multiple pharmacies, ration their medication, seek alternatives or deal with withdrawal symptoms. Half of the physicians have directly witnessed the Adderall shortage in their practices, according to a recent Sermo survey of 348 physicians. Demand for Adderall is increasing.…
GSK announces plans for new headquarters in London
GSK plc (LSE/NYSE:GSK) has announced its plans to move to its global headquarters to a new building in central London in 2024. The company is currently based in Brentford, a suburban town in West London. GSK isn’t the only Big Pharma company to announce a headquarters change. In late November, Sanofi (Nasdaq:SNY) moved its home base to…
Pfizer to invest billions in plants in Europe
Pharma giant Pfizer (NYSE:PFE) plans to spend more than $2.5 billion in facilities in Belgium and Ireland as it looks to diversify its product portfolio, according to Reuters. In 2021, Pfizer generated $36.9 billion in sales from the Comirnaty COVID-19 vaccine. The company projects its COVID-19 vaccine to rake in $34 billion in 2022, but COVID-related sales…
Catalent lays off workers, expands clinical supply facility in Shanghai
Contract manufacturing giant Catalent has wrapped up the expansion of a clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China. The company is also cutting 400 temporary and full-time workers in Bloomington, Indiana and more than 210 workers in Texas and Maryland. In a statement from Bloomington, Indiana Mayor John Hamilton blames the…
FDA yanks EUA for Lilly’s bebtelovimab COVID-19 antibody
The FDA has pulled the emergency use authorization (EUA) for bebtelovimab, the monoclonal antibody from Eli Lilly (NYSE:LLY), because it no longer adequately protects against the BQ.1 and BQ.1.1 omicron subvariants. In late November, the BQ.1 variant was responsible for 27.9% of U.S. COVID-19 infections, according to CDC. The BQ.1.1 variant represented 29.4% of infections. Meanwhile,…
AstraZeneca sells Ohio manufacturing site to National Resilience
AstraZeneca (LON:AZN) has sold its site in West Chester, Ohio, to National Resilience, a San Diego–headquartered biomanufacturing company. Resilience has agreed to maintain the site’s operations and assets while retaining its employees, including executives. The company will also continue investing in the site’s workforce and facility. Privately-held National Resilience also has separately announced that it…
Sanofi opens new Paris global headquarters
Sanofi (Euronext:SAN and Nasdaq:SNY) has announced that it has moved into its new international headquarters to Paris’s 17th arrondissement neighborhood, which is located on the right bank of the Seine River. The news headquarters, situated at 46-48 Avenue de la Grande Armée, was designed to promote novel ways to collaborate. Measuring 9,000 m² in area,…
AmpleLogic embraces low-code approach to help pharma companies digitally transform
Many pharmaceutical companies have recently ramped up their focus on digital transformation. But in the highly regulated pharma industry, digital transformation programs can be slow and expensive. Hyderabad, India–based AmpleLogic works with pharma companies to launch and scale digital transformation initiatives via its low-code platform, which can standardize and accelerate innovation in the industry, according…